Glaucoma News

KIAWAH ISLAND, S.C. — In this presentation from Kiawah Eye, Leon W. Herndon Jr., MD, explores the future of sustained-release drug delivery for glaucoma treatment, which may help improve patient compliance.

Blue-light filtering IOLs exhibited an advantage in favorable glaucoma outcomes after cataract surgery over non-blue-light filtering lenses, according to a study published in the Journal of Glaucoma.

There was a stronger association between myopia and incidence of primary open-angle glaucoma among Asian, Black and Hispanic Medicare beneficiaries in California vs. non-Hispanic white beneficiaries, according to a study.

A cohort of patients with high myopia experienced significantly low levels of thinning in the peripapillary retinal nerve fiber layer in the temporal quadrant and macular retinal nerve fiber layer, according to a pilot study.

KIAWAH ISLAND, S.C. — In a presentation at Kiawah Eye, Sarah H. Van Tassel, MD, discusses lifestyle interventions that ophthalmologists should encourage in their patients with glaucoma.

KIAWAH ISLAND, S.C. — In a presentation from Kiawah Eye, Thomas W. Samuelson, MD, discusses data supporting laser therapy as the first option for glaucoma treatment and upcoming laser technology.

Visiox Pharma has entered into a definitive agreement with Santen Pharmaceutical to license product manufacturing and commercialization rights for Omlonti in the U.S., according to a press release.

KIAWAH ISLAND, S.C. — In a presentation at Kiawah Eye, Nathan M. Radcliffe, MD, shares videos on performing surgery in patients with small pupils.

Eye drops for glaucoma are associated with various adverse effects on the ocular surface that often lead to treatment nonadherence and poor outcomes with surgery, according to a report published in Ocular Surface.

The year’s second issue of the Video Journal of Cataract, Refractive, and Glaucoma Surgery, which provides high-quality video-based education for anterior segment surgeons, is now online.